USPTO serial 88576540
OXTHERA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 24, 2021
- Examiner
- LEE, REBECCA ANN
- Law office
- TMO LAW OFFICE 129
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with OXTHERA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $797*
Plus Government fees of $975
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
OxThera Intellectual Property AB
Stockholm, SE
OxThera Intellectual Property AB
Stockholm, SE
OxThera Intellectual Property AB
Stockholm, SE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
Donna J. Bunton NIXON & VANDERHYE P.C.901 NORTH GLEBE ROAD, 11TH FLOORARLINGTON, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for use in urology, nephrology, gastroenterology, oncology and immunology and for the treatment of diabetes, infectious diseases, inflammation and metabolic diseases, all for therapeutic use; pharmaceutical preparations for the treatment of kidney stones; pharmaceutical products for the treatment and prevention of kidney diseases in patients with hyperoxaluria | ACTIVE | — |
| 035 | Retail store services featuring goods in the fields of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices; goods import-export agencies; sales promotion for others in the fields of pharmaceuticals, medical preparations, vaccines, natural remedies, diagnostics and medical devices | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the fields of pharmaceutics, tissue engineering and regenerative medicine; analysis of industrial fluids and scientific research services; medical, biological, chemical and scientific research; industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine; pharmaceutical research and development; research and development of new products in the nature of new medicines and medical preparations; medical and chemical laboratories; clinical testing, namely, conducting clinical trials for others in the fields of pharmaceutical preparations, drugs, cell therapy, gene therapy and cancer therapy; development of new products in the nature of probes, reagents and bioassays for industrial and scientific purposes; advisory, consultancy and information services relating to the provision of the aforesaid mentioned services, namely, advisory and consultancy services relating to medical, biological, chemical and scientific research, industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine, pharmaceutical research and development and conducting clinical trials and providing information in the fields of medical research, biological research, chemical research, scientific research and industrial research in the fields of pharmaceutics, tissue engineering and regenerative medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by OxThera Intellectual Property AB
- Other trademarks owned by OxThera Intellectual Property AB
- Other trademarks owned by OxThera Intellectual Property AB
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named OXTHERA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 24, 2026 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Aug 24, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 8, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 8, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 19, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 3, 2021 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 30, 2021 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Apr 29, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 29, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 29, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 29, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 29, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Apr 29, 2021 | OTHE | CASE RETURNED TO EXAMINATION | — |
| Apr 29, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Apr 15, 2021 | PCBG | PETITION TO DIRECTOR - CHANGE BASIS - GRANTED | — |
| Apr 12, 2021 | APET | ASSIGNED TO PETITION STAFF | — |
| Jan 12, 2021 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jan 11, 2021 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jan 11, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Dec 23, 2020 | EXT1 | SOU EXTENSION 1 FILED | — |
| Dec 23, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 23, 2020 | TPDR | TEAS PETITION TO DIRECTOR RECEIVED | — |
| Jun 30, 2020 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 5, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 5, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 15, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 26, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 19, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2020 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 21, 2020 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 21, 2020 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Feb 21, 2020 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2020 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 21, 2020 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 19, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 19, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 16, 2019 | NWAP | NEW APPLICATION ENTERED | — |